Questionnaire

1. Data from the United Kingdom demonstrated that 50% of all asthma-related deaths occurred in patients with an asthma severity that was considered to be:

2. Asthma-related deaths are more likely to occur at home or out of hospital.

3. After discontinuing ICS, asthma-related deaths increase within:

4. Eosinophilic airway inflammation, increased blood eosinophils and increased fractional exhaled nitrous oxide are a feature of:

5. In children with controlled HDM-driven allergic asthma, the preferred AIT as add-on to regular asthma therapy is:

6. The initial COPD treatment recommended by the 2023 GOLD guidelines is:

7. Adverse effects associated with ICS exposure from >1 year in the patient with COPD include an increased risk of:

8. In bronchiectasis, changes to neutrophils that occur upon exposure to the airway environment promote neutrophil dysfunction and a failure to clear bacteria, impaired phagocytosis, deficient killing of Pseudomonas, and delayed apoptosis giving rise to greater numbers of necrotic neutrophils.

9. An Enterobacteriaceae-dominant microbiome in patients with bronchiectasis has been associated with:

10. Evidence suggests that irrespective of the size of the pneumothorax, an initial intercostal drain is associated with better outcomes than conservative management of spontaneous pneumothorax.

11. Factors that influence delivery of an inhaled antibiotic in the ICU setting include the:

12. The ELF concentration of which inhaled antibiotic has been demonstrated to be 28- to 35-fold greater than with IV administration and with higher concentrations in non-aerated regions?

13. The most frequent adverse effects associated with nebulised amikacin or colistin include:

14. A programme-based study in Brazil evaluating clofazimine in MDR-TB found that approximately 50% of patients experienced the adverse effect of:

15. An adaptive TB treatment strategy that is based on rifampicin-linezolid or bedaquiline-linezolid and identifies patients with persistent clinical disease involves initial treatment, prior to reassessment, of: